Bank of New York Mellon’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Bank of New York Mellon’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-31,622	Closed	-$1.26M	–	4380
2016 Q3	$1.26M	Buy	31,622 +10,728	+51%	+$120K	﹤0.01%	3053
2016 Q2	$263K	Buy	+20,894	New	+$195K	﹤0.01%	3800
2015 Q2	–	Sell	-7,128	Closed	-$78K	–	4368
2015 Q1	$78K	Sell	7,128 -25	-0.3%	-$268	﹤0.01%	4097
2014 Q4	$58K	Sell	7,153 -115	-2%	-$990	﹤0.01%	4133
2014 Q3	$74K	Hold	7,268	–	–	﹤0.01%	4116
2014 Q2	$444K	Buy	+7,268	New	+$442K	﹤0.01%	3637

Bank of New York Mellon's TBRA Position: Q4 2016 in Review

Bank of New York Mellon sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 31,622 shares — an estimated $1.26M sold.

Bank of New York Mellon first reported a position in TBRA in Q2 2014 and held it in 6 quarters. The position peaked at $1.26M in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

Bank of New York Mellon reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Bank of New York Mellon sold 31,622 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $1.26M.
Bank of New York Mellon first reported a position in Tobira Therapeutics, Inc. Common Stock in Q2 2014 and held it in 6 quarters.
Bank of New York Mellon's Tobira Therapeutics, Inc. Common Stock position peaked at $1.26M in Q3 2016.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Bank of New York Mellon's 13F filing for Q4 2016, filed 13 Feb 2017.